DHR Stock Overview
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
My Notes
NewNotes are coming soon
Danaher Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$262.75 |
52 Week High | US$303.82 |
52 Week Low | US$233.71 |
Beta | 0.82 |
1 Month Change | -1.01% |
3 Month Change | 8.33% |
1 Year Change | -8.54% |
3 Year Change | 61.43% |
5 Year Change | 170.74% |
Change since IPO | 27,022.58% |
Recent News & Updates
Danaher Q4 2022 Earnings Preview
Jan 23Does Danaher (NYSE:DHR) Deserve A Spot On Your Watchlist?
Jan 16We Have A Winner! Revisiting Danaher And Thermo Fisher
Jan 11Recent updates
Does Danaher (NYSE:DHR) Deserve A Spot On Your Watchlist?
Jan 16A Look At The Fair Value Of Danaher Corporation (NYSE:DHR)
Dec 18When Should You Buy Danaher Corporation (NYSE:DHR)?
Dec 04Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?
Nov 20Is Now The Time To Put Danaher (NYSE:DHR) On Your Watchlist?
Oct 12A Look At The Intrinsic Value Of Danaher Corporation (NYSE:DHR)
Sep 16Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?
Sep 04Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?
Jul 19Should You Be Adding Danaher (NYSE:DHR) To Your Watchlist Today?
Jul 06Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)
Jun 09Is It Time To Consider Buying Danaher Corporation (NYSE:DHR)?
May 27These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Safely
Apr 12Should You Be Adding Danaher (NYSE:DHR) To Your Watchlist Today?
Mar 28Danaher (NYSE:DHR) Has A Rock Solid Balance Sheet
Dec 30Here's Why I Think Danaher (NYSE:DHR) Is An Interesting Stock
Dec 15These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Safely
Oct 01If You Like EPS Growth Then Check Out Danaher (NYSE:DHR) Before It's Too Late
Sep 16Estimating The Fair Value Of Danaher Corporation (NYSE:DHR)
Aug 31Is Danaher (NYSE:DHR) A Risky Investment?
Jul 02Here's Why I Think Danaher (NYSE:DHR) Is An Interesting Stock
Jun 17Is Danaher Corporation (NYSE:DHR) Trading At A 25% Discount?
Jun 02Shareholder Returns
DHR | US Life Sciences | US Market | |
---|---|---|---|
7D | -3.3% | -2.2% | 0.2% |
1Y | -8.5% | -14.5% | -13.6% |
Return vs Industry: DHR exceeded the US Life Sciences industry which returned -14.5% over the past year.
Return vs Market: DHR exceeded the US Market which returned -13.6% over the past year.
Price Volatility
DHR volatility | |
---|---|
DHR Average Weekly Movement | 4.9% |
Life Sciences Industry Average Movement | 11.7% |
Market Average Movement | 6.9% |
10% most volatile stocks in US Market | 17.3% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: DHR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: DHR's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1969 | 81,000 | Rainer Blair | https://www.danaher.com |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
Danaher Corporation Fundamentals Summary
DHR fundamental statistics | |
---|---|
Market Cap | US$191.36b |
Earnings (TTM) | US$7.10b |
Revenue (TTM) | US$31.47b |
26.9x
P/E Ratio6.1x
P/S RatioIs DHR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DHR income statement (TTM) | |
---|---|
Revenue | US$31.47b |
Cost of Revenue | US$12.52b |
Gross Profit | US$18.95b |
Other Expenses | US$11.85b |
Earnings | US$7.10b |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 9.75 |
Gross Margin | 60.21% |
Net Profit Margin | 22.57% |
Debt/Equity Ratio | 39.3% |
How did DHR perform over the long term?
See historical performance and comparison